Use of OB-101 to treat inflammation
AssigneeThe Texas A&M University System
InventorGeorge C. Y. Chiou
Life of this patent
Estimating the term…
Abstract
A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye, as well as in other parts of the body.
Claims5
A method for the treatment and prevention of inflammation in an animal subject which method comprises administering to said subject an inflammation-controlling effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable vehicle in admixture with a compound having the formula ##STR4##
Dependencies are inferred from the claim text.